Rational inhibitor design for Pseudomonas aeruginosa salicylate adenylation enzyme PchD

J Biol Inorg Chem. 2022 Sep;27(6):541-551. doi: 10.1007/s00775-022-01941-8. Epub 2022 May 5.

Abstract

Pseudomonas aeruginosa is an increasingly antibiotic-resistant pathogen that causes severe lung infections, burn wound infections, and diabetic foot infections. P. aeruginosa produces the siderophore pyochelin through the use of a non-ribosomal peptide synthetase (NRPS) biosynthetic pathway. Targeting members of siderophore NRPS proteins is one avenue currently under investigation for the development of new antibiotics against antibiotic-resistant organisms. Here, the crystal structure of the pyochelin adenylation domain PchD is reported. The structure was solved to 2.11 Å when co-crystallized with the adenylation inhibitor 5'-O-(N-salicylsulfamoyl)adenosine (salicyl-AMS) and to 1.69 Å with a modified version of salicyl-AMS designed to target an active site cysteine (4-cyano-salicyl-AMS). In the structures, PchD adopts the adenylation conformation, similar to that reported for AB3403 from Acinetobacter baumannii.

Keywords: Adenylation domain; Antibiotic resistance; Inhibitor design; Pseudomonas aeruginosa; Pyochelin.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Phenols
  • Pseudomonas aeruginosa* / metabolism
  • Salicylates / metabolism
  • Siderophores* / chemistry
  • Thiazoles

Substances

  • Anti-Bacterial Agents
  • Phenols
  • Salicylates
  • Siderophores
  • Thiazoles
  • pyochelin